Cite
HARVARD Citation
Agostini, M. et al. (n.d.). 1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab. Open forum infectious diseases. p. . [Online].